Researchers discover metabolite linked to aggressive prostate cancer
Researchers from the University of Michigan Comprehensive Cancer Center have identified a panel of small molecules, or metabolites, that appear to indicate aggressive prostate cancer. The finding could lead to a simple test that would help doctors determine which prostate cancers are slow-growing and which require immediate, aggressive treatment.
Results of the study appear in the Feb. 12 issue of Nature.
"One of the biggest challenges we face in prostate cancer is determining if the cancer is aggressive. We end up overtreating our patients because physicians don't know which tumors will be slow-growing. With this research, we have identified a potential marker for the aggressive tumors," says senior study author Arul Chinnaiyan, M.D., Ph.D., director of the Michigan Center for Translational Pathology and S.P. Hicks Endowed Professor of Pathology at the U-M Medical School.
The researchers looked at 1,126 metabolites across 262 samples of tissue, blood or urine associated with benign prostate tissue, early stage prostate cancer and advanced, or metastatic, prostate cancer. They mapped the alterations in metabolites and identified about 10 that were present more often in prostate cancer than in the benign cells and were present most often in the advanced cancer samples.
"When we're looking at metabolites, we're looking several steps beyond genes and proteins. It allows us to look very deeply at some of the functions of the cells and the biochemistry that occurs during cancer development," says Chinnaiyan, a Howard Hughes Medical Institute investigator.
One metabolite in particular, sarcosine, appeared to be one of the strongest indicators of advanced disease. Levels of sarcosine, an amino acid, were elevated in 79 percent of the metastatic prostate cancer samples and in 42 percent of the early stage cancer samples. Sarcosine was not found at all in the cancer-free samples.
In the study, sarcosine was a better indicator of advancing disease than the traditional prostate specific antigen, or PSA, test that is currently used to monitor or screen for prostate cancer. Sarcosine was detected in the urine, which has researchers hopeful that a simple urine test could be used.
In addition, the researchers found that sarcosine is involved in the same pathways that are linked to cancer invasiveness. This suggests sarcosine as a potential target for future drug development.
"This research gets at characterizing the chemical complexity of a sample of blood. In the future, this science will drive how doctors make treatment recommendations for their patients," says study author Christopher Beecher, Ph.D., professor of pathology at the U-M Medical School.
Results are preliminary at this point and will need years of further testing and development before this technology would be available for patients.
Source: University of Michigan Health System
Articles on the same topic
- Researchers find new biomarker for fatal prostate cancerFri, 13 Feb 2009, 5:22:34 UTC
- Survey of metabolites finds new prostate cancer markerWed, 11 Feb 2009, 18:22:49 UTC
- New treatment hope for prostate cancerFri, 6 Feb 2009, 15:32:18 UTC
Other sources
- New drug targets prostate cancerfrom Science AlertSat, 14 Feb 2009, 11:42:52 UTC
- Researchers find new biomarker for fatal prostate cancerfrom PhysorgFri, 13 Feb 2009, 14:07:35 UTC
- New Biomarker For Fatal Prostate Cancer Foundfrom Science DailyFri, 13 Feb 2009, 13:21:52 UTC
- New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreadingfrom Science DailyThu, 12 Feb 2009, 1:28:44 UTC
- Metabolite Linked to Aggressive Prostate Cancerfrom PhysorgWed, 11 Feb 2009, 18:42:25 UTC
- A better tip-off for prostate cancerfrom Sciencenews.orgWed, 11 Feb 2009, 17:56:53 UTC
- Research suggests possible urine test for prostate cancerfrom CBC: Technology & ScienceWed, 11 Feb 2009, 17:49:46 UTC
- Research suggests possible urine test for prostate cancerfrom CBC: HealthWed, 11 Feb 2009, 17:49:44 UTC
- Prostate cancer biomarker could speed diagnosisfrom Chemistry WorldWed, 11 Feb 2009, 17:35:15 UTC
- Prostate cancer test set to transform treatmentfrom The Guardian - ScienceWed, 11 Feb 2009, 17:29:37 UTC
- Well: Love in the Time of Prostate Cancerfrom NY Times HealthTue, 10 Feb 2009, 12:28:06 UTC
- New Treatment Hope For Prostate Cancerfrom Science DailyMon, 9 Feb 2009, 14:14:58 UTC
- New drug targets prostate cancerfrom Science AlertSun, 8 Feb 2009, 12:35:08 UTC
- New treatment hope for prostate cancerfrom PhysorgFri, 6 Feb 2009, 15:29:03 UTC